Avalo Therapeutics (AVTX) Gains from Investment Securities (2018 - 2024)
Avalo Therapeutics (AVTX) posted Gains from Investment Securities of $135.6 million for Q4 2024, up 476.32% on a QoQ basis from -$36.0 million in Q3 2024.
Avalo Therapeutics (AVTX) Gains from Investment Securities (2018 - 2024) Analysis & Trends
Avalo Therapeutics' Gains from Investment Securities history runs 4 years deep, the most recent figure standing at $135.6 million for Q4 2024.
- Quarterly Gains from Investment Securities changed N/A year-over-year to $135.6 million in Q4 2024, while the trailing twelve-month figure through Dec 2025 was $135.6 million (up 103.02% YoY) and the FY2024 annual result came in at -$12.5 million, changed N/A from the prior year.
- Gains from Investment Securities was $135.6 million for Q4 2024 at Avalo Therapeutics, up from -$36.0 million in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $1.7 billion in Q4 2022 and bottomed at -$112.0 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Avalo Therapeutics | 395.30 Mn | 338.15 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 135.57 Mn |
| Dec 31, 2024 | 135.57 Mn |
| Sep 30, 2024 | -36.03 Mn |
| Sep 30, 2024 | -36.03 Mn |
| Jun 30, 2024 | -112.05 Mn |
| Jun 30, 2024 | -112.05 Mn |
| Mar 31, 2024 | 79.28 Mn |
| Mar 31, 2024 | 79.28 Mn |
| Dec 31, 2022 | 1.70 Bn |
| Dec 31, 2022 | 1.70 Bn |
| Dec 31, 2019 | -1.00 |
| Dec 31, 2019 | -1.00 |
| Sep 30, 2019 | -197,220.00 |
| Sep 30, 2019 | -197,220.00 |
| Jun 30, 2019 | -992,350.00 |
| Jun 30, 2019 | -992,350.00 |
| Mar 31, 2019 | 180,402.00 |
| Mar 31, 2019 | 180,402.00 |
| Dec 31, 2018 | -302,484.00 |
| Dec 31, 2018 | -302,484.00 |